Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: HHS Gets $35M Shot In Arm To Expand Telehealth For Family Planning

Executive Summary

The US Department of Health and Human Services said on 23 November that the money will be used “to enhance and expand the telehealth infrastructure and capacity of Title X family planning providers.”

You may also be interested in...



Biden Signs ‘Historic’ $1.9Tn COVID-19 Relief Package Boosting Funding For Diagnostics, PPE

The monies are primarily allocated to helping Americans facing economic hardships due to the pandemic, but also includes tens of billions to bolster COVID-19 testing efforts.

FDA Warning Letter Recap, November 2021: 3 Device Makers Cited After On-Site Inspections

Invacare, Smiths Medical and CellEra were cited for quality systems and Medical Device Reporting violations in the only device-related warning letters released by the agency last month.

FDA Preps Device Makers To Use eSTAR For De Novo Requests

Manufacturers can’t use the US FDA’s voluntary eSTAR product submission program for de novo requests until January – but they can start practicing now on how to use eSTAR for that review pathway.

Topics

UsernamePublicRestriction

Register

MT144760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel